<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=STAT1</id>
	<title>STAT1 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=STAT1"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=STAT1&amp;action=history"/>
	<updated>2026-05-15T11:47:14Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=STAT1&amp;diff=4429&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84)  ==Publications==  {{medline-entry |title=Bioinform...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=STAT1&amp;diff=4429&amp;oldid=prev"/>
		<updated>2021-04-29T19:17:43Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84)  ==Publications==  {{medline-entry |title=Bioinform...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84)&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/33112891&lt;br /&gt;
|abstract=The World Health Organization declared the COVID-19 epidemic a public health emergency of international concern on March 11th, 2020, and the pandemic is rapidly spreading worldwide. COVID-19 is caused by a novel coronavirus SARS-CoV-2, which enters human target cells via angiotensin converting enzyme 2 ([[ACE2]]). We used a number of bioinformatics tools to computationally characterize [[ACE2]] by determining its cell-specific expression in trachea, lung, and small intestine, derive its putative functions, and predict transcriptional regulation. The small intestine expressed higher levels of [[ACE2]] mRNA than any other organ. By immunohistochemistry, duodenum, kidney and testis showed strong signals, whereas the signal was weak in the respiratory tract. Single cell RNA-Seq data from trachea indicated positive signals along the respiratory tract in key protective cell types including club, goblet, proliferating, and ciliary epithelial cells; while in lung the ratio of [[ACE2]]-expressing cells was low in all cell types (&amp;lt;2.6%), but was highest in vascular endothelial and goblet cells. Gene ontology analysis suggested that, besides its classical role in the renin-angiotensin system, [[ACE2]] may be functionally associated with angiogenesis/blood vessel morphogenesis. Using a novel tool for the prediction of transcription factor binding sites we identified several putative binding sites within two tissue-specific promoters of the [[ACE2]] gene as well as a new putative short form of [[ACE2]]. These include several interferon-stimulated response elements sites for [[STAT1]], [[IRF8]], and [[IRF9]]. Our results also confirmed that age and gender play no significant role in the regulation of [[ACE2]] mRNA expression in the lung.&lt;br /&gt;
|mesh-terms=* Aging&lt;br /&gt;
* Angiotensin-Converting Enzyme 2&lt;br /&gt;
* Betacoronavirus&lt;br /&gt;
* Binding Sites&lt;br /&gt;
* COVID-19&lt;br /&gt;
* Carrier Proteins&lt;br /&gt;
* Computational Biology&lt;br /&gt;
* Coronavirus Infections&lt;br /&gt;
* Female&lt;br /&gt;
* Gene Expression Regulation, Enzymologic&lt;br /&gt;
* Gene Ontology&lt;br /&gt;
* Humans&lt;br /&gt;
* Interferons&lt;br /&gt;
* Lung&lt;br /&gt;
* Male&lt;br /&gt;
* Metalloproteases&lt;br /&gt;
* Neovascularization, Physiologic&lt;br /&gt;
* Organ Specificity&lt;br /&gt;
* Pandemics&lt;br /&gt;
* Peptidyl-Dipeptidase A&lt;br /&gt;
* Pneumonia, Viral&lt;br /&gt;
* Promoter Regions, Genetic&lt;br /&gt;
* RNA, Messenger&lt;br /&gt;
* Receptors, Virus&lt;br /&gt;
* Renin-Angiotensin System&lt;br /&gt;
* SARS-CoV-2&lt;br /&gt;
* Sex Characteristics&lt;br /&gt;
* Single-Cell Analysis&lt;br /&gt;
* Transcription Factors&lt;br /&gt;
* Transcription Initiation Site&lt;br /&gt;
* Virus Attachment&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592753&lt;br /&gt;
}}&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=[[STAT1]]-p53-p21axis-dependent stress-induced progression of chronic nephrosis in adriamycin-induced mouse model.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32953802&lt;br /&gt;
|abstract=Chronic nephrosis (CN) is an aging-related disease with high mortality. Signal transduction and transcriptional activator 1 ([[STAT1]]) protein promotes senescence in human glomerular mesangial cells (HMCs), but whether it affects the progression of adriamycin (ADR)-induced CN [i]in vivo[/i] remains unclear. We established an ADR-induced CN mouse model that was completed in wild-type (wt) mice by a single intravenous injection of 10 mg/kg ADR for 2 or 4 weeks. Clinical indexes in each group were determined. Hematoxylin and eosin staining (H&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>